Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.87 USD | -0.45% | +9.38% | -21.19% |
31/05 | Ionis Reports 'Positive Results' From Studies of Investigational Treatment for Hereditary Angioedema | MT |
31/05 | Transcript : Ionis Pharmaceuticals, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.19% | 5.84B | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- IONS Stock
- News Ionis Pharmaceuticals, Inc.
- Ionis Pharmaceuticals : Partner Biogen Says Tofersen Study Failed to Meet Primary Goal; Shares Slip